Your browser doesn't support javascript.
loading
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5.
Wharton, Sean; Batterham, Rachel L; Bhatta, Meena; Buscemi, Silvio; Christensen, Louise N; Frias, Juan P; Jódar, Esteban; Kandler, Kristian; Rigas, Georgia; Wadden, Thomas A; Garvey, W Timothy.
Afiliação
  • Wharton S; York University, McMaster University, and Wharton Weight Management Clinic, Burlington, Ontario, Canada.
  • Batterham RL; Division of Medicine, University College London Centre for Obesity Research, University College London, London, UK.
  • Bhatta M; National Institute of Health Research, University College London Hospital Biomedical Research Centre, London, UK.
  • Buscemi S; Centre for Weight Management and Metabolic Surgery, University College London Hospital, London, UK.
  • Christensen LN; Novo Nordisk A/S, Søborg, Denmark.
  • Frias JP; Unit of Clinical Nutrition, Policlinico University Hospital, Palermo, Italy.
  • Jódar E; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Kandler K; Novo Nordisk A/S, Søborg, Denmark.
  • Rigas G; National Research Institute, Los Angeles, California, USA.
  • Wadden TA; School of Medicine, Universidad Europea de Madrid, Madrid, Spain.
  • Garvey WT; Department of Endocrinology and Nutrition Service, Hospital Universitario Quironsalud Madrid, Madrid, Spain.
Obesity (Silver Spring) ; 31(3): 703-715, 2023 03.
Article em En | MEDLINE | ID: mdl-36655300

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ingestão de Alimentos / Sobrepeso Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ingestão de Alimentos / Sobrepeso Idioma: En Ano de publicação: 2023 Tipo de documento: Article